Evaxion Biotech A/S (EVAX)

1.81

-0.13 (-6.70%)

At close: Mar 03, 2025, 3:59 PM

1.89

4.25%

After-hours: Mar 03, 2025, 04:00 PM EST

Evaxion Biotech A/S Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-22.13M	-23.17M	-24.53M	-15.02M	-11.2M	-5.54M
Depreciation & Amortization	615K	571K	344K	105K	81K	74K
Stock-Based Compensation	479K	942K	1.38M	3.41M	2.36M	2.07M
Other Working Capital	-48.7K	-2.28M	1.88M	-1.58M	-7K	13K
Other Non-Cash Items	2.76M	-243K	-171K	919K	1.99M	1.16M
Deferred Income Tax	-984K	-998K	-190K	-2.07M	-825K	-735K
Change in Working Capital	1.56M	-2.88M	1.24M	215K	566K	981K
Operating Cash Flow	-17.69M	-25.77M	-21.93M	-12.44M	-7.03M	-1.99M
Capital Expenditures	-87K	-292K	-1.36M	-393K	-61K	-7K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-6K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	24.01K	29.95K	n/a	n/a	n/a
Other Investing Acitivies	133.00	-13	48.00	-244K	-7K	13K
Investing Cash Flow	-93K	-268K	-1.33M	-393K	-61K	6K
Debt Repayment	-632K	7.42M	-289K	n/a	79K	7.93M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.15M	n/a	-3.76M	-202K	-13K	n/a
Financial Cash Flow	10.69M	7.85M	49.8M	8.82M	9.51M	9.03M
Net Cash Flow	-7.6M	-18.98M	26.33M	-3.73M	2.13M	6.96M
Free Cash Flow	-17.78M	-26.07M	-23.29M	-12.83M	-7.09M	-2M